Literature DB >> 20128659

Characterization of microRNAs involved in embryonic stem cell states.

Bradford Stadler1, Irena Ivanovska, Kshama Mehta, Sunny Song, Angelique Nelson, Yunbing Tan, Julie Mathieu, Christopher Darby, C Anthony Blau, Carol Ware, Garrick Peters, Daniel G Miller, Lanlan Shen, Michele A Cleary, Hannele Ruohola-Baker.   

Abstract

Studies of embryonic stem cells (ESCs) reveal that these cell lines can be derived from differing stages of embryonic development. We analyzed common changes in the expression of microRNAs (miRNAs) and mRNAs in 9 different human ESC (hESC) lines during early commitment and further examined the expression of key ESCenriched miRNAs in earlier developmental states in several species. We show that several previously defined hESC-enriched miRNA groups (the miR-302, -17, and -515 families, and the miR-371-373 cluster) and several other hESC-enriched miRNAs are down-regulated rapidly in response to differentiation. We further found that mRNAs up-regulated upon differentiation are enriched in potential target sites for these hESC-enriched miRNAs. Interestingly, we also observed that the expression of ESC-enriched miRNAs bearing identical seed sequences changed dynamically while the cells transitioned through early embryonic states. In human and monkey ESCs, as well as human-induced pluripotent stem cells (iPSCs), the miR-371-373 cluster was consistently up-regulated, while the miR-302 family was mildly down-regulated when the cells were chemically treated to regress to an earlier developmental state. Similarly, miR-302b, but not mmu-miR-295, was expressed at higher levels in murine epiblast stem cells (mEpiSC) as compared with an earlier developmental state, mouse ESCs. These results raise the possibility that the relative expression of related miRNAs might serve as diagnostic indicators in defining the developmental state of embryonic cells and other stem cell lines, such as iPSCs. These data also raise the possibility that miRNAs bearing identical seed sequences could have specific functions during separable stages of early embryonic development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20128659      PMCID: PMC3128320          DOI: 10.1089/scd.2009.0426

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  59 in total

1.  Direct and sensitive miRNA profiling from low-input total RNA.

Authors:  Hui Wang; Robert A Ach; Bo Curry
Journal:  RNA       Date:  2006-11-14       Impact factor: 4.942

Review 2.  Derive and conquer: sourcing and differentiating stem cells for therapeutic applications.

Authors:  Irina Klimanskaya; Nadia Rosenthal; Robert Lanza
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

3.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

Review 4.  Guiding embryonic stem cells towards differentiation: lessons from molecular embryology.

Authors:  Francesca M Spagnoli; Ali Hemmati-Brivanlou
Journal:  Curr Opin Genet Dev       Date:  2006-08-17       Impact factor: 5.578

5.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

6.  Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro.

Authors:  P W Andrews
Journal:  Dev Biol       Date:  1984-06       Impact factor: 3.582

7.  Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro.

Authors:  P W Andrews; I Damjanov; D Simon; G S Banting; C Carlin; N C Dracopoli; J Føgh
Journal:  Lab Invest       Date:  1984-02       Impact factor: 5.662

8.  REST maintains self-renewal and pluripotency of embryonic stem cells.

Authors:  Sanjay K Singh; Mohamedi N Kagalwala; Jan Parker-Thornburg; Henry Adams; Sadhan Majumder
Journal:  Nature       Date:  2008-03-23       Impact factor: 49.962

9.  Embryonic stem cell-specific microRNAs promote induced pluripotency.

Authors:  Robert L Judson; Joshua E Babiarz; Monica Venere; Robert Blelloch
Journal:  Nat Biotechnol       Date:  2009-04-12       Impact factor: 54.908

10.  MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells.

Authors:  Srikumar Sengupta; Jeff Nie; Ryan J Wagner; Chuhu Yang; Ron Stewart; James A Thomson
Journal:  Stem Cells       Date:  2009-07       Impact factor: 6.277

View more
  76 in total

1.  Comprehensive microRNA expression profiling of the hematopoietic hierarchy.

Authors:  O I Petriv; F Kuchenbauer; A D Delaney; V Lecault; A White; D Kent; L Marmolejo; M Heuser; T Berg; M Copley; J Ruschmann; S Sekulovic; C Benz; E Kuroda; V Ho; F Antignano; T Halim; V Giambra; G Krystal; C J F Takei; A P Weng; J Piret; C Eaves; M A Marra; R K Humphries; C L Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-11       Impact factor: 11.205

Review 2.  Genome-wide approaches in the study of microRNA biology.

Authors:  Melissa L Wilbert; Gene W Yeo
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

Review 3.  Epigenetic alterations in human parathyroid tumors.

Authors:  Chiara Verdelli; Irene Forno; Valentina Vaira; Sabrina Corbetta
Journal:  Endocrine       Date:  2015-02-27       Impact factor: 3.633

Review 4.  The Function of TrophomiRs and Other MicroRNAs in the Human Placenta.

Authors:  Yoel Sadovsky; Jean-Francois Mouillet; Yingshi Ouyang; Avraham Bayer; Carolyn B Coyne
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-15       Impact factor: 6.915

5.  Hypoxia-inducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency.

Authors:  Julie Mathieu; Wenyu Zhou; Yalan Xing; Henrik Sperber; Amy Ferreccio; Zsuzsa Agoston; Kavitha T Kuppusamy; Randall T Moon; Hannele Ruohola-Baker
Journal:  Cell Stem Cell       Date:  2014-03-20       Impact factor: 24.633

6.  HIF induces human embryonic stem cell markers in cancer cells.

Authors:  Julie Mathieu; Zhan Zhang; Wenyu Zhou; Amy J Wang; John M Heddleston; Claudia M A Pinna; Alexis Hubaud; Bradford Stadler; Michael Choi; Merav Bar; Muneesh Tewari; Alvin Liu; Robert Vessella; Robert Rostomily; Donald Born; Marshall Horwitz; Carol Ware; C Anthony Blau; Michele A Cleary; Jeremy N Rich; Hannele Ruohola-Baker
Journal:  Cancer Res       Date:  2011-06-28       Impact factor: 12.701

7.  MicroRNA target sites as genetic tools to enhance promoter-reporter specificity for the purification of pancreatic progenitor cells from differentiated embryonic stem cells.

Authors:  Ulf Diekmann; Matthias Elsner; Jan Fiedler; Thomas Thum; Sigurd Lenzen; Ortwin Naujok
Journal:  Stem Cell Rev Rep       Date:  2013-10       Impact factor: 5.739

8.  Two miRNA clusters reveal alternative paths in late-stage reprogramming.

Authors:  Ronald J Parchem; Julia Ye; Robert L Judson; Marie F LaRussa; Raga Krishnakumar; Amy Blelloch; Michael C Oldham; Robert Blelloch
Journal:  Cell Stem Cell       Date:  2014-03-13       Impact factor: 24.633

9.  Developmentally programmed 3' CpG island methylation confers tissue- and cell-type-specific transcriptional activation.

Authors:  Da-Hai Yu; Carol Ware; Robert A Waterland; Jiexin Zhang; Miao-Hsueh Chen; Manasi Gadkari; Govindarajan Kunde-Ramamoorthy; Lagina M Nosavanh; Lanlan Shen
Journal:  Mol Cell Biol       Date:  2013-03-04       Impact factor: 4.272

10.  Protein arginine methyltransferase 7-mediated microRNA-221 repression maintains Oct4, Nanog, and Sox2 levels in mouse embryonic stem cells.

Authors:  Tsai-Yu Chen; Sung-Hun Lee; Shilpa S Dhar; Min Gyu Lee
Journal:  J Biol Chem       Date:  2018-01-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.